Delpor
PrivateLast Round
Grant
Nov 16, 2021
Total Funding Raised
$10.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Delpor is a clinical-stage biopharmaceutical company that develops once-yearly therapies for chronic diseases using innovative subcutaneous implant technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delpor Comparables
Compare Delpor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReacX Pharmaceuticals, Inc. | 84% | |
| Black Titan Corporation | 83% | |
| BioCorRx Inc | 81% |
Delpor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 16, 2021 | ||||
| Grant | Oct 14, 2019 | ||||
| Grant | Jun 14, 2017 | ||||
| Grant | Feb 9, 2017 | ||||
| Series A | Mar 28, 2016 | ||||
Grant | Jun 20, 2012 |
Delpor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Fondazione Hub Innovazione Trentino | VC Round |
| NIH RADx | Grant |
| Cloudstone Capital | VC Round |
| Kairos Ventures | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Ulu Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 2314% MoM, from 119 to 2.9K.
- Jul 20, 2026
Hired 5 new employees, representing 100% of headcount.
Delpor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delpor's valuation, stock price, and market status.
Is Delpor a public or private company?
Delpor is a private company.
What is the current stock price of Delpor?
Delpor is a private company with no public stock price. No recent secondary market data is available.
How much is Delpor worth (valuation)?
Valuation information for Delpor is not publicly available.
Can I buy Delpor stock?
Delpor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delpor's last funding round?
Delpor's most recent funding round was Grant on November 16, 2021.
Who are the main investors in Delpor?
Key investors in Delpor include National Institute of Mental Health, NIH RADx, Kairos Ventures, National Institute of Diabetes and Digestive and Kidney Diseases.
Will Delpor IPO soon?
No public IPO plans have been announced for Delpor.
How can I track Delpor secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delpor's secondary market activity and sign up for updates.